Lifecore Biomedical, Inc. \De\
Nasdaq · Healthcare · Pharmaceutical Preparations · Chaska, MN
LFCR chart
What traders are saying about $LFCR
Latest postsLifecore Biomedical, Inc. \De\ news
- Braemar Unveils Highly Qualified Independent Board Slate for Company’s New Chapter
Yahoo Finance ·
- Lifecore Biomedical, Inc. (LFCR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Is Lifecore Biomedical (LFCR) an Asymmetric Risk-Reward in Pharma Contract Manufacturing?
Yahoo Finance ·
- Lifecore Biomedical to Participate at Upcoming Industry Conferences
Yahoo Finance ·
- Lifecore Biomedical to be Acquired by Webster Equity Partners
Yahoo Finance ·
- Lifecore Biomedical to Participate at CPHI Global Conference
Yahoo Finance ·
- Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
Yahoo Finance ·
- Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
Yahoo Finance ·
- Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript
fool.com ·
- Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Lifecore Biomedical Inc (LFCR) (Q2 2026) Earnings Call Highlights: Strategic Wins and Capacity ...
Yahoo Finance ·
- Lifecore Biomedical Q2 Earnings Call Highlights
marketbeat.com ·
Lifecore Biomedical, Inc. \De\ key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | – | -$38.7M | $12.0M | -$99.6M |
| Diluted EPS | – | $-1.27 | $0.33 | $-3.32 |
| Total assets (year end) | $232.2M | $255.4M | $245.8M | $276.0M |
| Cash and equivalents (year end) | $17.5M | $9.5M | – | $5.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lifecore Biomedical, Inc. \De\
- Ticker
- LFCR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chaska, MN
- Incorporated in
- DE
- Fiscal year end
- May 25
- SEC CIK
- 1005286
- Former names
- LANDEC CORP \CA\
Frequently asked questions
What exchange is Lifecore Biomedical, Inc. \De\ listed on?
Lifecore Biomedical, Inc. \De\ trades on the Nasdaq under the ticker symbol LFCR.
What industry is Lifecore Biomedical, Inc. \De\ in?
Lifecore Biomedical, Inc. \De\ is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lifecore Biomedical, Inc. \De\ headquartered?
Lifecore Biomedical, Inc. \De\'s business address on file with the SEC is in Chaska, MN.
When does Lifecore Biomedical, Inc. \De\'s fiscal year end?
Lifecore Biomedical, Inc. \De\'s fiscal year ends on May 25.
How much revenue did Lifecore Biomedical, Inc. \De\ report?
Lifecore Biomedical, Inc. \De\ reported $557.6M in revenue for calendar year 2018, according to its SEC filings.